The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects - PubMed (original) (raw)
- PMID: 3993694
The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects
M G Aman et al. Am J Ment Defic. 1985 Mar.
Abstract
The development of a scale to assess drug and other treatment effects on severely mentally retarded individuals was described. In the first stage of the project, an initial scale encompassing a large number of behavior problems was used to rate 418 residents. The scale was then reduced to an intermediate version, and in the second stage, 509 moderately to profoundly retarded individuals were rated. Separate factor analyses of the data from the two samples resulted in a five-factor scale comprising 58 items. The factors of the Aberrant Behavior Checklist have been labeled as follows: (I) Irritability, Agitation, Crying; (II) Lethargy, Social Withdrawal; (III) Stereotypic Behavior; (IV) Hyperactivity, Noncompliance; and (V) Inappropriate Speech. Average subscale scores were presented for the instrument, and the results were compared with empirically derived rating scales of childhood psychopathology and with factor analytic work in the field of mental retardation.
Similar articles
- Cross-validation of the factor structure of the Aberrant Behavior Checklist for persons with mental retardation.
Bihm EM, Poindexter AR. Bihm EM, et al. Am J Ment Retard. 1991 Sep;96(2):209-11. Am J Ment Retard. 1991. PMID: 1930950 - Psychometric characteristics of the aberrant behavior checklist.
Aman MG, Singh NN, Stewart AW, Field CJ. Aman MG, et al. Am J Ment Defic. 1985 Mar;89(5):492-502. Am J Ment Defic. 1985. PMID: 3158201 Clinical Trial. - Diagnosis and treatment of psychiatric and behavioural disorders in mentally retarded individuals: the state of the art.
Dosen A. Dosen A. J Intellect Disabil Res. 1993 Oct;37 Suppl 1:1-7. J Intellect Disabil Res. 1993. PMID: 8274825 Review. - Reliability of the Aberrant Behavior Checklist and the effect of variations in instructions.
Aman MG, Singh NN, Turbott SH. Aman MG, et al. Am J Ment Defic. 1987 Sep;92(2):237-40. Am J Ment Defic. 1987. PMID: 3434595 - The assessment of social functioning in individuals with mental retardation: a review.
Bielecki J, Swender SL. Bielecki J, et al. Behav Modif. 2004 Sep;28(5):694-708. doi: 10.1177/0145445503259828. Behav Modif. 2004. PMID: 15296526 Review.
Cited by
- No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder.
Vo LC, Snyder C, McCracken C, McDougle CJ, McCracken JT, Aman MG, Tierney E, Arnold LE, Levi D, Kelleman M, Carroll D, Morrissey J, Vitiello B, Scahill L. Vo LC, et al. J Child Adolesc Psychopharmacol. 2016 Dec;26(10):900-908. doi: 10.1089/cap.2016.0090. Epub 2016 Oct 11. J Child Adolesc Psychopharmacol. 2016. PMID: 27726426 Free PMC article. Clinical Trial. - Risperidone dosing in children and adolescents with autistic disorder: a double-blind, placebo-controlled study.
Kent JM, Kushner S, Ning X, Karcher K, Ness S, Aman M, Singh J, Hough D. Kent JM, et al. J Autism Dev Disord. 2013 Aug;43(8):1773-83. doi: 10.1007/s10803-012-1723-5. J Autism Dev Disord. 2013. PMID: 23212807 Clinical Trial. - Conducting research with minimally verbal participants with autism spectrum disorder.
Tager-Flusberg H, Plesa Skwerer D, Joseph RM, Brukilacchio B, Decker J, Eggleston B, Meyer S, Yoder A. Tager-Flusberg H, et al. Autism. 2017 Oct;21(7):852-861. doi: 10.1177/1362361316654605. Epub 2016 Jun 26. Autism. 2017. PMID: 27354431 Free PMC article. - A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders.
Ghanizadeh A, Moghimi-Sarani E. Ghanizadeh A, et al. BMC Psychiatry. 2013 Jul 25;13:196. doi: 10.1186/1471-244X-13-196. BMC Psychiatry. 2013. PMID: 23886027 Free PMC article. Clinical Trial. - The role of emotion regulation in autism spectrum disorder.
Mazefsky CA, Herrington J, Siegel M, Scarpa A, Maddox BB, Scahill L, White SW. Mazefsky CA, et al. J Am Acad Child Adolesc Psychiatry. 2013 Jul;52(7):679-88. doi: 10.1016/j.jaac.2013.05.006. Epub 2013 Jun 3. J Am Acad Child Adolesc Psychiatry. 2013. PMID: 23800481 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources